Profhilo.jpg

PROFHILO TRAINING

Prerequisites:

NVQ Level 3 or Equivalent

Duration:

Home Study and

1/2 day Practical Session

 

Cost:

£350.00

Course Information

This course qualifies you for CPD points and insurance cover. It covers the core knowledge behind the treatment and practical training so you can safely and effectively carry out Profhilo treatments for Face.

This Profhilo Skin Booster Injections Course is designed to qualify you in how to inject Profhilo safely and effectively and understand who the product works in the skin.

There are 5 key injection points that will be covered within your course, to ensure that your client has the best outcome for their skin.

 

Profhilo Injections have become more popular with clients looking to improve their skin tone, reduce the appearance of fine lines and wrinkles and firm the lower part of the face and neck but do not want dermal fillers. 

Course Content

  • Revision of Health & Safety 

  • Revision of Skin A&P  

  • Skin Health  

  • What is Profhilo?

  • Theory of Hyaluronic Acid

  • Protocols for covered areas

  • Pre and Post treatment procedures

  • Client consultation

  • Managing expectations and complaints procedure

  • Treatment area and injection techniques

  • Pain management protocols (common side effects) 

  • Hands-on practice 

  • Q & A  

  • Marketing Advice 

Includes:

  • Printed protocols for easy reference

  • Downloadable consultation form

  • Downloadable aftercare leaflets

  • On going support

Treatment Information

PROFHILO® is based on stabilsed hybrid cooperative complex, and it is the pioneer of bioremodelling.

It is the first product developed with NAHYCO® technology, a unique and innovative thermal production process, 100% free of chemical stabilising agents, patented by IBSA.

PROFHILO® is indicated for tissue remodeling and improvement in skin laxity of face, neck, and décolletage.

 

Unique characteristics of the product are: natural HA with a duration comparable to a low cross-linked gel, high HA concentration (64mg/2ml), high manageability, extensive spreadability, low viscosity, no BDDE or other chemical agents, and low inflammatory response.